PD-L1 testing and CPS interpretation in oesophageal cancer

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Click here to download. PD-L1 testing and CPS interpretation in oesophageal cancer

PDF, 686 KB

Download this leaflet for more information on PD-L1 testing and CPS scoring in oesophageal cancer.

CPS = Combined Positive Score.

More information about KEYTRUDA® (pembrolizumab) in locally advanced unresectable or metastatic oesophageal cancer

Visit product page

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) 
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-PDO-02346 | Date of Preparation: August 2022